series-a
Stage
1
Investors
About
Feliqs is a clinical-stage ophthalmology company developing innovative small-molecule therapeutics to treat neonatal ophthalmic diseases such as Retinopathy of Prematurity, with clinical trials underway in the United States.
Explore Feliqs's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.